Catalyst Wire Dossier Catalyst Wire Dossier

Varubi (rolapitant)

rolapitant · Tesaro, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Varubi (rolapitant), covering 2015-11-04 to 2015-11-04. Get the full timeline:

Most recent: Clinical Trial Update: Ph 3 Safety/Efficacy Study of Rolapitant for Prevention of CINV in Subjects Receiving Moderately Emetogenic Chemotherapy [Phase 3]

See pricing